| Literature DB >> 28447199 |
George Younan1, Susan Tsai1, Douglas B Evans1, Kathleen K Christians2.
Abstract
The altered anatomy in patients after bariatric surgery who have undergone a Roux-en-Y gastric bypass may pose a technical challenge for surgical removal of the pancreatic head. We treat patients with pancreas cancer with multimodality therapy in a neoadjuvant fashion followed by pancreaticoduodenectomy (PD). In patients with Roux-en-Y gastric bypass anatomy, the gastric remnant is preserved and used for pancreaticogastrostomy reconstruction and subsequently drained by the same jejunal limb used for the hepaticojejunostomy. This method of reconstruction takes advantage of the previous surgically altered anatomy and avoids the morbidity of a gastric remnant resection at the time of PD.Entities:
Keywords: Gastric bypass; Gastric remnant; Pancreaticoduodenectomy; Pancreaticogastrostomy
Mesh:
Year: 2017 PMID: 28447199 PMCID: PMC5486682 DOI: 10.1007/s11605-017-3405-2
Source DB: PubMed Journal: J Gastrointest Surg ISSN: 1091-255X Impact factor: 3.452
Fig. 1a RYGB anatomy prior to PD; a tumor is seen in the head of the pancreas. b The resulting anatomy post PD specimen removal; the jejunal limb is proximal to the previous jejunojejunostomy and is used for the reconstruction. c the PD anatomy after completion of the reconstruction with a PG; the jejunal limb is brought in a retrocolic fashion and used for the biliary and gastric remnant drainage
Summary of published series to date on PD after gastric bypass
| Study | #Patients | Gastric Remnant | Pathology | Reconstruction |
|---|---|---|---|---|
| Khithani et al., | 2 | 0 | PDAC | PJ |
| Rutkoski et al., | 1 | 1 | PDAC | PJ |
| Swain et al., | 5 | 1 | PDAC, AC, PNETx2 | PJ |
| Nikfarjam et al., | 2 | 0 | Benign CBD stricture | PJ |
| de la Cruz-Muñoz et al., | 1 | 0 | PNET | PJ |
| Theodoropoulos et al., | 1 | 1 | PDAC | PJ |
| Helmick et al., | 2 | 2 | IPMN, Benign/fibrosis | PJ |
PDAC pancreatic ductal adenocarcinoma, AC ampullary carcinoma, PNET pancreatic neuroendocrine tumor, IPMN intraductal papillary mucinous neoplasm, PJ pancreaticojejunostomy